• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区女性乳腺单纯黏液癌的临床病理特征和长期预后

Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.

机构信息

Comprehensive Breast Cancer Center, Changhua Christian Hospital, 135 Nanhsiao Street, Changhua 50006, Taiwan.

出版信息

World J Surg Oncol. 2013 Jun 14;11:139. doi: 10.1186/1477-7819-11-139.

DOI:10.1186/1477-7819-11-139
PMID:23768133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3689603/
Abstract

BACKGROUND

Pure mucinous carcinoma (MC) is found in about 3.5% of all newly diagnosed breast cancer patients in Taiwan. MC is a relatively rare malignancy of breast cancer, and its nature, behaviors, treatment pattern and long-term follow-up are not well understood. The study aimed to investigate the incidence rate, treatment patterns, and prognostic factors of MC of the breast and the clinical long-term outcomes compared with infiltrating ductal carcinoma not otherwise specified (IDC) in the middle and south Taiwanese women.

METHODS

Data from 93 patients with breast MC were retrospectively reviewed and the clinicopathologic characteristics and survival status were compared with those of 2,674 patients with IDC.

RESULTS

The expression of hormonal receptor was higher in MC than those in IDC (P <0.001). MC also demonstrated lower Her2/neu gene over-expression (P = 0.023), less axillary lymph node involvement (P <0.0001), lymphovascular invasion (P <0.0001) and higher 10-year overall survival rate (P = 0.042), when compared with those of IDC.

CONCLUSION

Our data confirm the less aggressive behavior of MC compared to IDC. MC showed favorable clinicopathologic characteristics in tumor grade, hormone receptor status and lymph node involvement in the middle and south Taiwanese women.

摘要

背景

在台湾,约有 3.5%的新诊断乳腺癌患者为纯黏液癌(MC)。MC 是乳腺癌中相对罕见的恶性肿瘤,其性质、行为、治疗模式和长期随访情况尚未得到很好的了解。本研究旨在调查台湾中南部女性乳腺癌 MC 的发病率、治疗模式和预后因素,并与非特殊型浸润性导管癌(IDC)进行临床长期结局比较。

方法

回顾性分析了 93 例乳腺 MC 患者的临床病理特征和生存状况,并与 2674 例 IDC 患者进行比较。

结果

MC 患者的激素受体表达率高于 IDC(P<0.001)。MC 患者的 Her2/neu 基因过表达率较低(P=0.023),腋窝淋巴结受累(P<0.0001)、脉管侵犯(P<0.0001)较少,10 年总生存率较高(P=0.042)。

结论

与 IDC 相比,MC 确实具有侵袭性较低的行为。在台湾中南部女性中,MC 表现出较好的肿瘤分级、激素受体状态和淋巴结受累的临床病理特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c04/3689603/df93d56c1207/1477-7819-11-139-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c04/3689603/df93d56c1207/1477-7819-11-139-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7c04/3689603/df93d56c1207/1477-7819-11-139-1.jpg

相似文献

1
Pure mucinous carcinoma of the breast: clinicopathologic characteristics and long-term outcome among Taiwanese women.台湾地区女性乳腺单纯黏液癌的临床病理特征和长期预后
World J Surg Oncol. 2013 Jun 14;11:139. doi: 10.1186/1477-7819-11-139.
2
Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.纯黏液性乳腺癌与浸润性导管癌的结局比较:来自中国的一项基于人群的研究。
Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6. Epub 2012 Mar 27.
3
Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise specified.中国髓样乳腺癌患者诊断时的临床病理特征与生存情况:与非特殊性浸润性导管癌的比较。
World J Surg Oncol. 2013 Apr 22;11:91. doi: 10.1186/1477-7819-11-91.
4
Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis.21 基因复发评分在单纯黏液性乳腺癌患者生存和分布的预测因素:一项基于 SEER 人群的回顾性分析。
Clin Breast Cancer. 2019 Feb;19(1):e66-e73. doi: 10.1016/j.clbc.2018.10.001. Epub 2018 Oct 13.
5
Comparison of the Distribution Pattern of 21-Gene Recurrence Score between Mucinous Breast Cancer and Infiltrating Ductal Carcinoma in Chinese Population: A Retrospective Single-Center Study.中国人群黏液性乳腺癌与浸润性导管癌 21 基因复发评分分布模式的比较:一项回顾性单中心研究。
Cancer Res Treat. 2020 Jul;52(3):671-679. doi: 10.4143/crt.2019.387. Epub 2020 Jan 28.
6
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.非转移性激素受体阳性 HER2 阴性纯黏液性乳腺癌的结局:一项多中心队列研究。
J Natl Compr Canc Netw. 2024 May 14;22(2 D):e237121. doi: 10.6004/jnccn.2023.7121.
7
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.对11400例纯黏液性乳腺癌病例进行长期随访的回顾性研究。
Breast Cancer Res Treat. 2008 Oct;111(3):541-7. doi: 10.1007/s10549-007-9809-z. Epub 2007 Nov 18.
8
Clinical Implication of HER2 Status in Hormone Receptor-Positive Mucinous Breast Cancer.激素受体阳性黏液性乳腺癌中 HER2 状态的临床意义。
Ann Surg Oncol. 2019 Jul;26(7):2166-2174. doi: 10.1245/s10434-019-07332-9. Epub 2019 Apr 11.
9
Mucinous Carcinoma of the Breast: Clinicopathological Features and Long-term Prognosis in Comparison with Invasive Ductal Cancer; A Single Hospital's 30+-Year Experience.乳腺黏液癌:与浸润性导管癌的临床病理特征和长期预后比较;单中心 30 余年经验。
Acta Med Okayama. 2020 Apr;74(2):137-143. doi: 10.18926/AMO/58272.
10
Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.浸润性导管癌患者中Ki-67、雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2/neu(Her2/neu)、p21、表皮生长因子受体(EGFR)和拓扑异构酶II-α(TOP II-α)表达之间的关系及其与预后的相关性。
Asian Pac J Cancer Prev. 2015;16(2):823-9. doi: 10.7314/apjcp.2015.16.2.823.

引用本文的文献

1
Race as a prognostic factor of breast mucinous carcinoma.种族作为乳腺黏液癌的一个预后因素。
J Cancer Res Clin Oncol. 2024 Dec 27;151(1):25. doi: 10.1007/s00432-024-06035-3.
2
Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics.年轻、中年和老年成年女性浸润性乳腺癌患者的临床和生活方式特征对 5 年生存预后的影响。
Breast Cancer Res Treat. 2024 Jun;205(3):619-631. doi: 10.1007/s10549-024-07280-3. Epub 2024 Mar 25.
3
Nomogram for predicting survival in patients with mucinous breast cancer undergoing chemotherapy and surgery: a population-based study.

本文引用的文献

1
Mucinous carcinomas of the breast: imaging features and potential for misdiagnosis.乳腺黏液癌:影像学特征及误诊可能性
J Med Imaging Radiat Oncol. 2013 Feb;57(1):25-31. doi: 10.1111/1754-9485.12006. Epub 2012 Dec 28.
2
Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features.雌激素将单纯黏液性乳腺癌转化为具有黏液特征的浸润性小叶癌。
Breast Cancer Res Treat. 2013 Jan;137(2):431-48. doi: 10.1007/s10549-012-2377-x. Epub 2012 Dec 18.
3
Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis.
基于人群的研究:预测接受化疗和手术的黏液性乳腺癌患者生存的列线图。
Eur J Med Res. 2023 Oct 10;28(1):415. doi: 10.1186/s40001-023-01395-x.
4
Mucinous Breast Carcinoma Presenting as a Coarse and Densely Calcified Mass on Mammography: A Case Report.乳腺黏液癌在乳腺钼靶上表现为粗大密集钙化肿块:一例报告
Taehan Yongsang Uihakhoe Chi. 2020 Sep;81(5):1266-1271. doi: 10.3348/jksr.2019.0083. Epub 2020 Aug 13.
5
Construction of a Prognostic Nomogram Model for Patients with Mucinous Breast Cancer.构建黏液性乳腺癌患者预后列线图模型。
J Healthc Eng. 2022 Mar 23;2022:1230812. doi: 10.1155/2022/1230812. eCollection 2022.
6
Clinicopathological Study of Mucinous Carcinoma of Breast with Emphasis on Cytological Features: A Study at Tertiary Care Teaching Hospital of South India.乳腺黏液癌的临床病理研究:重点关注细胞学特征——印度南部三级护理教学医院的一项研究
J Lab Physicians. 2020 Mar;12(1):68-75. doi: 10.1055/s-0040-1714935. Epub 2020 Aug 11.
7
Breast-conserving therapy shows better prognosis in mucinous breast carcinoma compared with mastectomy: A SEER population-based study.保乳治疗在黏液性乳腺癌中的预后优于乳房切除术:一项 SEER 基于人群的研究。
Cancer Med. 2020 Aug;9(15):5381-5391. doi: 10.1002/cam4.3202. Epub 2020 Jun 8.
8
Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis.黏液性乳腺癌:文献回顾和回顾性三级单中心分析。
Breast. 2020 Feb;49:87-92. doi: 10.1016/j.breast.2019.11.002. Epub 2019 Nov 11.
9
Comparison of Clinical Features and Treatment Results of Mix Mucinous Carcinomas and Other Atypical Carcinomas of the Breast.乳腺黏液混合癌与其他非典型乳腺癌的临床特征及治疗结果比较
Eur J Breast Health. 2019 Oct 1;15(4):222-228. doi: 10.5152/ejbh.2019.5032. eCollection 2019 Oct.
10
Expression of vascular endothelial growth factor and caspase-3 in mucinous breast carcinoma and infiltrating ductal carcinoma-not otherwise specified, and the correlation with disease-free survival.血管内皮生长因子和半胱天冬酶-3在黏液性乳腺癌和浸润性导管癌(非特殊类型)中的表达及其与无病生存期的相关性
Oncol Lett. 2017 Oct;14(4):4890-4896. doi: 10.3892/ol.2017.6744. Epub 2017 Aug 10.
乳腺黏液癌与浸润性导管癌的比较:临床病理特征和预后。
J Breast Cancer. 2011 Dec;14(4):308-13. doi: 10.4048/jbc.2011.14.4.308. Epub 2011 Dec 27.
4
Clinicopathological evaluation of 100 cases of mucinous carcinoma of breast with emphasis on axillary staging and special reference to a micropapillary pattern.100 例乳腺黏液癌的临床病理评估,重点是腋窝分期,并特别关注微乳头状模式。
J Clin Pathol. 2010 Dec;63(12):1043-7. doi: 10.1136/jcp.2010.082495. Epub 2010 Oct 20.
5
Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special type.乳腺黏液癌在基因组上有别于非特殊型浸润性导管癌。
J Pathol. 2010 Nov;222(3):282-98. doi: 10.1002/path.2763.
6
Expression of androgen, estrogen and progesterone receptors in mucinous carcinoma of the breast.雄激素、雌激素和孕激素受体在乳腺黏液癌中的表达。
Kaohsiung J Med Sci. 2008 May;24(5):227-32. doi: 10.1016/S1607-551X(08)70146-3.
7
A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.对11400例纯黏液性乳腺癌病例进行长期随访的回顾性研究。
Breast Cancer Res Treat. 2008 Oct;111(3):541-7. doi: 10.1007/s10549-007-9809-z. Epub 2007 Nov 18.
8
Uncommon breast tumors in perspective: incidence, treatment and survival in the Netherlands.透视罕见乳腺肿瘤:荷兰的发病率、治疗与生存情况
Int J Cancer. 2007 Jul 1;121(1):127-35. doi: 10.1002/ijc.22625.
9
Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer.雌激素受体状态与淋巴结阳性乳腺癌患者现代化疗的疗效
JAMA. 2006 Apr 12;295(14):1658-67. doi: 10.1001/jama.295.14.1658.
10
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.早期乳腺癌化疗和激素治疗对复发及15年生存率的影响:随机试验综述
Lancet. 2005;365(9472):1687-717. doi: 10.1016/S0140-6736(05)66544-0.